This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Jeffrey Vernice
Director, Patient Excellence at Boehringer Ingelheim Pharmaceuticals, Inc.
Speaker

Profile

Jeff Vernice is a Director of Patient Excellence at Boehringer Ingelheim. He leads a team responsible for end-to-end patient journey strategy and their solutions connecting providers, patients and pharmacies. Jeff has expertise in patient services with prior manufactures across several therapeutic areas such as CRM, neuroscience, oncology and immunology in addition to deep experiences with payors such as a health plan and a PBM in disciplines such as product management, marketing and analytics.

Agenda Sessions

  • Section 1: Orchestrating the Pre-Launch Symphony – Building Cross-Functional Harmony

    1:00pm